Relay Therapeutics Inc

2026. g. 18. sept. 20:06 UTC

Relay Therapeutics Inc shares fell sharply after an early peak, trading below its 20-day moving average and near the lower end of its one-month range.

2026. g. 17. sept. 19:46 UTC

Relay Therapeutics Inc is trading higher, having reached a peak earlier before pulling back, and has gained since Wednesday's close.

2026. g. 16. sept. 20:13 UTC

Relay Therapeutics Inc saw modestly lower trading during after-market hours, remaining unchanged since Wednesday's close and below its 20-day moving average.

2026. g. 15. sept. 19:46 UTC

Relay Therapeutics Inc shares are lower, reflecting negative market sentiment after the NY Empire State Manufacturing Index fell sharply to 7.6 for September.

2026. g. 14. sept. 20:21 UTC

Relay Therapeutics Inc. shares advanced in after-market trading, rebounding from earlier lows and reflecting a shift within a routine range since Monday's close.

2026. g. 10. sept. 19:16 UTC

Relay Therapeutics Inc is trading higher, recovering from an earlier dip. No specific news was identified, though broader market sentiment may be influencing shares.

2026. g. 9. sept. 23:31 UTC

Relay Therapeutics Inc is trading higher in after-market hours, advancing since Wednesday's close despite a broader market decline amid rising oil prices and inflation concerns.

2026. g. 8. sept. 20:07 UTC

Relay Therapeutics shares are higher, continuing an upward trend since Friday's close, though they remain below the 20-day moving average.

2026. g. 2. sept. 20:08 UTC

Relay Therapeutics will participate in two investor conferences in September 2026. Shares are trading roughly flat since Tuesday's close, below the 20-day moving average.

2026. g. 31. aug. 20:07 UTC

Relay Therapeutics shares are lower today amid broader market pressures and concerns about inflation following the Jackson Hole Economic Symposium.

2026. g. 28. aug. 21:51 UTC

Relay Therapeutics Inc is trading higher in after-market hours, rebounding from three consecutive lower sessions. No specific news was identified for this movement.

2026. g. 27. aug. 22:01 UTC

Relay Therapeutics Inc shares are lower in after-market trading, declining from earlier gains amid broader weakness and three consecutive sessions of losses.

2026. g. 26. aug. 20:08 UTC

Relay Therapeutics Inc is trading lower today amid broader market declines, influenced by inflation data that exceeded expectations and may impact Federal Reserve policy.

2026. g. 25. aug. 23:41 UTC

Relay Therapeutics Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2026. g. 24. aug. 19:56 UTC

Relay Therapeutics is testing a buy point at $20.79, reflecting ongoing interest. The stock remains higher since Friday's close despite an earlier pullback.

2026. g. 21. aug. 21:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, up significantly since Friday's close and above its 20-day moving average.

2026. g. 20. aug. 20:02 UTC

Relay Therapeutics Inc shares are lower today, influenced by a decline in the broader Biotechnology sector and significant market volatility. Trading volume remains unusually high.

2026. g. 19. aug. 23:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, positioned near the upper end of its one-month range and above its 20-day moving average.

2026. g. 18. aug. 22:26 UTC

Relay Therapeutics Inc. shares traded lower after market hours, reflecting broader market pressure from rising bond yields and inflation concerns.

2026. g. 17. aug. 19:36 UTC

Relay Therapeutics Inc is trading higher amid a Phase 3 trial for its breast cancer treatment and a $53 million investment from Baker Bros.

2026. g. 14. aug. 21:51 UTC

Relay Therapeutics Inc is gaining in after-market trading, supported by social media discussions and a significant portfolio stake from Perceptive Advisors.

2026. g. 13. aug. 19:16 UTC

Relay Therapeutics Inc is trading lower, reflecting broader declines in the biotechnology sector amid fluctuations and rising initial jobless claims.

2026. g. 10. aug. 19:56 UTC

Relay Therapeutics shares are higher after Citizens raised its price target to $26, citing confidence in the company's Phase 3 trials.

2026. g. 7. aug. 20:06 UTC

Barclays raised its price target on Relay Therapeutics to $30.00, contributing to positive sentiment amid ongoing analyst support following the company's Q2 earnings.

2026. g. 6. aug. 23:02 UTC

Relay Therapeutics shares are lower in after-market hours following disappointing Q2 results, including a net loss of $83.7 million and revenue of $350,000.

2026. g. 5. aug. 22:26 UTC

Relay Therapeutics Inc. shares advanced in after-market trading, maintaining a position above its 20-day moving average amid broader macroeconomic sentiment.

2026. g. 4. aug. 19:26 UTC

Relay Therapeutics Inc is trading higher during Tuesday's session, continuing its upward trend since Monday's close. Broader market sentiment supports this performance.

2026. g. 3. aug. 21:01 UTC

Relay Therapeutics Inc shares are lower in after-market trading, continuing a downward trend amid three consecutive sessions of declines and no specific news.

2026. g. 31. jūl. 19:16 UTC

Relay Therapeutics Inc shares are lower in Friday's session, reflecting broader declines in the biotech sector amid rising yields and inflation concerns.

2026. g. 30. jūl. 17:36 UTC

Relay Therapeutics Inc is rising as it advances its PI3Kα inhibitor for breast cancer treatment, drawing renewed interest and nearing IPO levels.